Featured Projects
Improved Pakistani Reproductive Health and Family Planning Services:
Key Social Marketing
Compared to other developing countries, Pakistan still has an unacceptably
high rate of population growth. The Government of Pakistan's
(GOP) objective is to reduce annual population growth from 2.1 percent (2001)
to 1.82 percent (2004) and 1.6 percent by 2012. Since GOP resources
are limited and donor support is finite, Constella Futures works to increase
the private sector's involvement in the provision of quality family
planning and reproductive health products and services to maximize the public
and donor resource base and help reach those who need them the most.
Specifically, Constella Futures is growing the overall contraceptive market,
fostering collaboration and healthy competition. Constella Futures also provides
sales, marketing, distribution and other technical support to local organizations,
building their capacity to create demand for and increase acceptance of contraceptives. Quality
control is one specific area on which Constella Futures focuses – ensuring
that locally manufactured and imported products meet or exceed international
standards. These commodities are not subsidized; rather they are targeted
toward those who can afford them freeing up government resources to target
the poorest of the poor.
One of the great successes of the Constella Futures approach is illustrated
through work with Zafa Pharmaceutical Laboratories, a company based in Pakistan. Under
Constella Futures guidance, Zafa entered the market as a hormonal contraceptive
manufacturer and developed a quality assurance plan. In addition, Constella
Futures has also worked to ensure that the two social marketing organizations
in Pakistan – Key Social Marketing and Greenstar/PSI – are now
working together, supporting each other's appropriate brands of products,
conducting joint training, driving policy and advocacy issues, and sharing
credit for the results.
USAID awarded the project to Constella Futures in collaboration with JHPIEGO.